Repeated out-of-Africa expansions of Helicobacter pylori driven by replacement of deleterious mutations.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 11 2022
Historique:
received: 05 01 2022
accepted: 26 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 16 11 2022
Statut: epublish

Résumé

Helicobacter pylori lives in the human stomach and has a population structure resembling that of its host. However, H. pylori from Europe and the Middle East trace substantially more ancestry from modern African populations than the humans that carry them. Here, we use a collection of Afro-Eurasian H. pylori genomes to show that this African ancestry is due to at least three distinct admixture events. H. pylori from East Asia, which have undergone little admixture, have accumulated many more non-synonymous mutations than African strains. European and Middle Eastern bacteria have elevated African ancestry at the sites of these mutations, implying selection to remove them during admixture. Simulations show that population fitness can be restored after bottlenecks by migration and subsequent admixture of small numbers of bacteria from non-bottlenecked populations. We conclude that recent spread of African DNA has been driven by deleterious mutations accumulated during the original out-of-Africa bottleneck.

Identifiants

pubmed: 36369175
doi: 10.1038/s41467-022-34475-3
pii: 10.1038/s41467-022-34475-3
pmc: PMC9652371
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6842

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5033-8
pubmed: 21383187
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):17758-64
pubmed: 23077256
Genetics. 1963 Oct;48:1303-12
pubmed: 14071753
Helicobacter. 2017 Aug;22(4):
pubmed: 28271597
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Mol Biol Evol. 2019 May 1;36(5):1101-1109
pubmed: 30590560
Genetics. 2012 Nov;192(3):1065-93
pubmed: 22960212
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Genetics. 2015 Jul;200(3):947-63
pubmed: 25995212
Mol Biol Evol. 2022 Feb 3;39(2):
pubmed: 35022759
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13880-5
pubmed: 23898187
Science. 2003 Mar 7;299(5612):1582-5
pubmed: 12624269
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12619-24
pubmed: 9770535
Curr Opin Genet Dev. 2016 Dec;41:150-158
pubmed: 27744216
PLoS Genet. 2018 Oct 22;14(10):e1007741
pubmed: 30346959
Nature. 2008 Feb 21;451(7181):994-7
pubmed: 18288194
Mol Biol Evol. 2000 Jan;17(1):32-43
pubmed: 10666704
G3 (Bethesda). 2014 Feb 19;4(2):325-39
pubmed: 24347631
Science. 2014 Feb 14;343(6172):747-751
pubmed: 24531965
PLoS Pathog. 2008 Oct;4(10):e1000180
pubmed: 18949030
Mol Biol Evol. 2007 Aug;24(8):1586-91
pubmed: 17483113
Science. 2016 Jan 8;351(6269):162-165
pubmed: 26744403
Science. 2018 May 11;360(6389):656-660
pubmed: 29674434
PLoS Genet. 2010 Jul 22;6(7):e1001036
pubmed: 20661309
Mol Biol Evol. 2013 Jun;30(6):1454-64
pubmed: 23505045
Evolution. 1995 Dec;49(6):1067-1080
pubmed: 28568521
Annu Rev Genet. 1982;16:1-19
pubmed: 6760797
Mutat Res. 1964 May;106:2-9
pubmed: 14195748
Microbiology (Reading). 2000 Apr;146 ( Pt 4):851-860
pubmed: 10784043
PLoS Genet. 2012;8(11):e1002967
pubmed: 23166502
J Integr Bioinform. 2013 Nov 15;10(3):233
pubmed: 24231147
Genetics. 2016 Jun;203(2):881-91
pubmed: 27038113
PLoS Pathog. 2012;8(5):e1002693
pubmed: 22589724
Microb Genom. 2022 Feb;8(2):
pubmed: 35188454
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15056-61
pubmed: 11742075
PLoS Genet. 2012 Jan;8(1):e1002453
pubmed: 22291602
PLoS Genet. 2017 Apr 14;13(4):e1006730
pubmed: 28410409
N Engl J Med. 2002 Oct 10;347(15):1175-86
pubmed: 12374879
PLoS Biol. 2007 Apr;5(4):e94
pubmed: 17407380
PLoS Genet. 2016 Jan 11;12(1):e1005774
pubmed: 26752180
PLoS One. 2013;8(1):e55120
pubmed: 23383074
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Mol Biol Evol. 2014 Jul;31(7):1929-36
pubmed: 24739305
Nature. 2007 Feb 22;445(7130):915-918
pubmed: 17287725

Auteurs

Harry A Thorpe (HA)

Department of Biostatistics, University of Oslo, Oslo, Norway.

Elise Tourrette (E)

CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.

Koji Yahara (K)

Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

Filipa F Vale (FF)

Pathogen Genome Bioinformatics and Computational Biology, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.

Siqi Liu (S)

CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
University of Chinese Academy of Sciences, Beijing, China.

Mónica Oleastro (M)

National Reference Laboratory for Gastrointestinal Infections, Department of Infectious Diseases, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.

Teresa Alarcon (T)

Department of Microbiology, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain.

Tsachi-Tsadok Perets (TT)

Gastroenterology Laboratory, Rabin Medical Center, Petah Tikva, Israel.
Department of Digital Medical Technologies, Holon Institute of Technology, Holon, Israel.

Saeid Latifi-Navid (S)

Department of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, Iran.

Yoshio Yamaoka (Y)

Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Oita, Japan.
Department of Medicine-Gastroenterology, Baylor College of Medicine, Houston, TX, USA.

Beatriz Martinez-Gonzalez (B)

Laboratory of Medical Microbiology, Hellenic Pasteur Institute, Athens, Greece.

Ioannis Karayiannis (I)

Laboratory of Medical Microbiology, Hellenic Pasteur Institute, Athens, Greece.

Timokratis Karamitros (T)

Laboratory of Medical Microbiology, Hellenic Pasteur Institute, Athens, Greece.

Dionyssios N Sgouras (DN)

Laboratory of Medical Microbiology, Hellenic Pasteur Institute, Athens, Greece.

Wael Elamin (W)

G42 Healthcare, Abu Dhabi, UAE.
Elrazi University, Khartoum, Sudan.

Ben Pascoe (B)

Department of Biology, University of Oxford, Oxford, UK.

Samuel K Sheppard (SK)

Ineos Oxford Institute, Department of Biology, University of Oxford, Oxford, UK.

Jukka Ronkainen (J)

Center for Life Course Health Research, University of Oulu, Oulu, Finland.
Primary Health Care Center, Tornio, Finland.

Pertti Aro (P)

Arokero Oy, Tornio, Finland.

Lars Engstrand (L)

Center for Translational Microbiome Research, Department for Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Lars Agreus (L)

Division of Family Medicine, Karolinska Institutet, Stockholm, Sweden.

Sebastian Suerbaum (S)

Department of Medical Microbiology and Hospital Epidemiology, Max von Pettenkofer Institute, Faculty of Medicine, LMU Munich, Munich, Germany.
Department of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hanover, Germany.
DZIF German Center for Infection Research, Hannover-Braunschweig and Munich Partner Sites, Munich, Germany.

Kaisa Thorell (K)

Institute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Daniel Falush (D)

CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China. danielfalush@googlemail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH